Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3774_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
20 Мб
Скачать
398
https://t.me/medicina_free
most common primary site of infection to be the respiratory tract (34%) followed by abdomen (25%), blood (17%), urinary tract (8%) and skin and soft tissue (7%) [10]. Although less common, CNS and endocardial infections are notable for their high morbidity and mortality. An international point prevalence study of infections in ICU patients found similar proportions although in contrast to the septic shock group respiratory tract infections accounted for 64% of infections [11]. In the latter study, microbiological culture results were positive in 70% of infected patients; 62% of the positive isolates were gram-negative organisms, 47% were gram­positive, and 19% were fungi. Patients who had longer ICU stays prior to the study day had higher rates of infection, especially infections due to resistant Staphylococcus, Acinetobacter, Pseudomonas and Candida species.
Antimicrobial resistance patterns vary enormously around the world and even between neighbouring institutions. Organisms resistant to practically all commonly used antimicrobials have now been described and empiric antibiotic regimes need to reect this unfortunate trend.
B. Reddi
17.4 Pathogenesis
17.4.1 Innate Immunity inSepsis
The rst response to an invading pathogen is mediated by the innate immune system. Pattern recognition receptors (such as Toll-like receptors (TLRs) and C-type lectin receptors) on the surface of macrophages, neutrophils, dendritic cells and natural killer cells recognise structurally conserved molecules that are broadly shared by pathogens such as lipoteichoic acid, peptidoglycan, lipopolysaccharide, agellin, viral RNA and mannan (a fungal cell wall carbohydrate). Intracellular pattern recog­nition receptors (such as NOD-like receptors) which recognise conserved bacterial and viral molecular patterns have also been identied. As well as these pathogen associated molecular patterns (PAMPs), receptors also bind endogenous ligands, termed damage associated molecular patterns (DAMPs), that enter the microenvi­ronment when host cells undergo non-apoptotic death. These molecules, which include fragments of nuclear and mitochondrial DNA, cytosolic heat shock proteins and chromatin associated high mobility group box 1 (HMGB1) instigate the inam­mation associated with trauma, burns and pancreatitis. Pattern recognition receptor signalling activates transcription factors such as NFκB which induce inammatory cytokine expression and promote immune cell maturation and proliferation [12]. Humoral elements of the immune system such as complement and the contact sys­tem of the coagulation cascade also bind to conserved elements of the microbial surface and contribute to innate immunity and the inammatory milieu [13].
Cytokines and complement fragments attract and activate local and circulating immune cells which amplify the inammatory cascade and exert direct microbicidal activity by liberating substances such as lysozyme and reactive oxygen species
17 Sepsis andSeptic Shock
https://t.me/medicina_free
(ROS). As well as direct antimicrobial activity, many cells of the innate immune system (for example macrophages and dendritic cells) act as antigen presenting cells, displaying antigen bound to major histocompatibility complex (MHC) to T-cells of the adaptive immune system. T-helper cells co-ordinate both the ongoing innate immune response and a more antigen specic T- and B-lymphocyte response.
399
17.4.2 Immunosuppression inSepsis
Most patents who die of sepsis in the ICU have unresolved foci of infection at post­mortem. Furthermore, patients admitted to hospital with sepsis frequently develop secondary nosocomial infections often with minimally virulent or opportunistic pathogens such as Stenotrophomonas, Acinetobacter, Candida or reactivated Cytomegalovirus. It has been suggested that following an initial pro-inammatory phase, sepsis manifests a subsequent anti-inammatory phase [14]. In support of this hypothesis it has been shown that inammatory cells extracted from patients with sepsis produce less tumour necrosis factor α (TNFα), interleukin-1 (IL-1) and IL-6 in response to lipopolysaccharide than controls. Furthermore, levels of the anti-inammatory cytokine IL-10 are elevated in patients with sepsis and the IL-10/ TNFα ratio correlates with mortality. Delayed type hypersensitivity reactions are impaired in sepsis and patients dying of sepsis exhibit profound apoptosis-induced loss of CD4 and CD8 T-lymphocytes, B-lymphocytes and dendritic cells with a shift towards immunoregulatory T-lymphocyte phenotype. Notably, therapies which sup­press inammatory cytokine activity such as TLR-4 and TNFα antagonists have failed to improve outcomes. These ndings suggest that sepsis and septic shock does not always reect a maladaptive hyper-inammatory response to infection but, at least in some cases, may identify a group of patients generating an inappropriate immune suppressive, anergic phenotype. Indeed preliminary data indicate that T-lymphocyte stimulating and anti-apoptotic agents (such as IL-7 and programmed death ligand-1 antagonism, respectively) might be more effective [14].
17.4.3 Microvascular Alterations inSepsis
TLRs are also expressed on endothelial cells where they promote leucocyte trafck­ing, tissue factor pathway activation and endothelial permeability. Endothelial per­meability is also increased by leucocyte and platelet derived arachidonic acid derivatives, platelet activating factor (PAF), complement products and glycocalyx shedding. Tissue oedema not only leads to hypovolaemia and increased blood vis­cosity but impairs oxygen and metabolite diffusion, changes tissue architecture, blocks capillary blood ow and lymphatic drainage, and is associated with renal, cerebral and cardiac dysfunction [15]. Glycocalyx shedding as a consequence of bacterial toxin and leucocyte mediated damage further exacerbates tissue oedema
400
https://t.me/medicina_free
and has been particularly noted in the kidney, liver and lung. Glycocalyx shedding also interferes with endothelial shear stress ow monitoring and vasomotor regulation.
Microvascular perfusion is further compromised by a shift to a local prothrom­botic prole: IL-6, ROS and bacterial toxins reduce ADAMTS-13 (a disintegrin and metalloproteinase with thrombospondin motifs) activity resulting in highly throm­botic von Willebrand Factor multimers. TNFα promotes tissue factor expression on macrophages and endothelial cells. Tissue factor pathway inhibitor, thrombomodu­lin and protein C activity are reduced, whilst plasminogen activator inhibitor is increased. Meanwhile endothelial cell damage and apoptosis leaves pro-thrombotic extracellular matrix exposed and inammatory cells secrete PAF. The net conse­quence is a tendency for thrombus formation and microvascular occlusion [16] although reduced platelet function has also been documented [17]. Cross-talk between the coagulation and immune systems promoting amplication and dissem­ination of local coagulopathy can lead to the systemic consumptive coagulopathy characteristic of disseminated intravascular coagulation.
Microvascular occlusion can also arise from the release of neutrophil extracel­lular traps (NETs), webs of chromatin barbed with antimicrobial proteins which trap and kill microorganisms. Whilst benecial in containing and clearing infection, NETs have been observed to occlude capillaries and exacerbate tissue damage [18]. In addition, regional vasomotor regulation (including metabolic and myogenic reg­ulation) is impaired by glycocalyx damage, endothelial damage, downregulation of endothelial nitric oxide synthase (eNOS) and secretion of local vasoconstrictors such as endothelin and thromboxane A2. NETs, clots, reduced erythrocyte deform­ability, leucocyte aggregates, extrinsic compression from tissue oedema and vaso­motor dysregulation lead to a decrease in the number of functional capillaries and heterogeneity in microvascular perfusion with blood shunted past islands of isch­aemic, hypoxic tissue through areas of relatively luxuriant ow. Patchy ischemia of this nature can be directly visualised in myocardium, renal cortex, gut and other vascular beds [19].
B. Reddi
17.4.4 Mitochondrial Dysfunction inSepsis
Mitochondria are responsible for oxidative phosphorylation and ATP synthesis, regulation of ROS and control of apoptosis. Activity of complex I, II and IV of the mitochondrial electron transport chain is signicantly reduced in critically ill patients with a corresponding decrease in ATP levels, possibly under the inuence of ROS, NO, TNFα and IL-1. Whether this is an adaptive response to limit oxygen consumption, ROS-mediated damage, or to promote aerobic glycolysis, or a conse­quence of cell injury which contributes to multiorgan dysfunction in sepsis, remains uncertain [20].
Microvascular shunting and mitochondrial dysfunction underlie the observation that an oxygen extraction decit and multi-organ dysfunction (MOD) can persist
17 Sepsis andSeptic Shock
https://t.me/medicina_free
401
despite resolution of macrovascular haemodynamic variables. Evidence of tissue hypoxia frequently co-exists with globally supranormal oxygen delivery and ele­vated mixed venous oxygen saturation.
17.4.5 Pathological Vasodilation inSeptic Shock
Septic shock is characterised by systemic hypotension and tissue hypoperfusion. Uncontrolled arterial vasodilation dissipates the head of pressure required to appro­priately distribute blood ow, whilst reduced venomotor tone (coupled with uid loss through leaky endothelium) reduces stressed venous volume, ventricular pre­load and cardiac output.
Pathological vasodilation is a manifestation of both increased baseline vessel calibre and reduced sensitivity to endogenous and administered vasoconstrictors. Inammatory cytokines promote the production of NO from the cationic amino acid L-arginine by activating inducible NOS (iNOS) in neutrophils and vascular smooth muscle cells. Compared to eNOS, iNOS produces far greater amounts of NO (nano­molar rather than picomolar) and lacks feedback control. iNOS inhibitors improve vascular tone and blood pressure in patients with septic shock but not their outcome [21], perhaps reecting the complexity of trying to interrupt an endogenous path­way which exerts both useful and toxic effects. Endothelium derived prostacyclin, the anaphylotoxins C3a and C5a (products of the complement cascade), PAF, adre­nomedullin and other endogenous vasodilators all contribute to pathological vaso­dilation. Septic shock is associated with initial spikes in plasma corticosteroid and vasopressin levels followed by relative deciencies in both [22, 23], whilst ROS oxidise and deactivate circulating noradrenaline. Moreover, even invitro, sensitivity to α1-receptor agonists is reduced in arterioles from animals with septic shock potentially as a consequence of receptor downregulation, increased myosin phos­phatase activity and increased ATP sensitive K
+
channel conductance [24, 25].
17.4.6 Sepsis Induced Cardiac Dysfunction
In early sepsis, cardiac output may be impaired despite normal contractility because of reduced preload secondary to venodilation, capillary uid leak and inadequate diastolic lling time. This may be partly overcome with uid loading and judicious vasopressor use. Sepsis is also associated with elevation in pulmonary vascular resistance, a possible consequence of endothelial injury; elevated right ventricular afterload contributes to impaired RV contractility and RV dilation (which may, in turn, compromise LV lling). In up to 50% of cases of sepsis, however, intrinsic myocardial systolic and diastolic function are depressed as part of the MOD syn­drome complicating sepsis. Postulated mechanisms of myocardial dysfunction in sepsis and septic shock are listed in Table 17.2 [26, 29]. Signicantly,
402
https://t.me/medicina_free
Table 17.2 Mechanisms of myocardial dysfunction in sepsis [26, 27]
Pathophysiological mechanism Causative factors
Downregulated β downstream pathway activity
Dysregulated Ca sarcoplasmic reticulum
Direct cardiomyocyte injury Bacterial toxins, ROS, leucocyte
Suppressed mitochondrial activity, reduced oxygen utilisation and loss of redox homeostasis
Mechanically compromised contraction and relaxation
-adrenergic receptors and
1
2+
transients, Ca2+ leak from
NO, TNFα, IL-1, other ‘myocardial depressant factors (MDF)
NO, ROS, MDF DAMPs, PAMPs binding to TLR Leucocyte binding to cardiomyocyte adhesion molecules [
degranulation, NETs, microvascular dysfunction, MDF
DAMPs, PAMPs binding to TLR ROS, NO, cytokines, MDF
Myocardial oedema
28]
B. Reddi
cardiomyocyte death is a rare event in sepsis and does not explain the degree of functional depression observed. A fundamental question is the extent to which observed alterations are protective versus maladaptive. For instance, NO reduces myocardial oxygen consumption, acts as a free radical scavenger, promotes coro­nary blood ow and improves ventricular compliance [29]. Interestingly survivors tend to have lower ejection fraction and larger LV end diastolic volume (EDV) than non- survivors suggesting that operating with higher ventricular preload is somehow protective in sepsis despite being energetically less favourable in health [27].
17.4.7 Other Sepsis Induced Organ Dysfunction
Sepsis is a multisystem disorder which can cause dysfunction in any organ system. Examples include encephalopathy, acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), acute liver injury, loss of gut integrity, polyneuropathy and myopathy.
Up to 65% of patients with septic shock will develop AKI.Once thought to be primarily driven by microcirculatory insufciency, it is now recognised that AKI often develops in the context of normal or high renal blood ow. Although micro­vascular dysfunction and local inammation can drive tubular injury the surpris­ingly bland histopathology and often rapid recovery suggest that some of the tubular dysfunction observed is functional and perhaps adaptive; cytokines, PAMPs and DAMPs induce cell cycle arrest and downregulate metabolism [28]. Encephalopathy frequently accompanies sepsis and is mediated by cerebral endothelial changes with increased blood:brain barrier permeability, ischaemic lesions, microabscesses and microglial activation [30]. Common themes in the multi-organ dysfunction (MOD)
17 Sepsis andSeptic Shock
https://t.me/medicina_free
syndrome are a causative role for inammatory cytokines and PAMPs/DAMPs, microvascular and endothelial dysregulation, suppressed mitochondrial activity and often functional impairment rather than necrosis, the latter suggesting that some elements of MOD reect adaptive changes to reduce cellular stress. Genetic evalu­ation is a promising future research direction, as certain polymorphisms in genes coding for cytokines are associated with more severe MOD.
403
17.5 Clinical Manifestations
Taking a rational history of symptoms, risk factors and exposures, accompanied by systematic clinical examination, often identies the presence and source of infec­tion. Patients progressing to sepsis typically present with dysregulated temperature, tachycardia, tachypnoea and leucocytosis/leucopaenia with organ dysfunction man­ifest as altered mental status (restlessness, delirium, obtundation), respiratory fail­ure, oliguria, ileus, jaundice or bleeding diathesis. Although a classical transition from a hyperdynamic circulation with bounding pulses and warm peripheries to a low cardiac output state, with cold, mottled skin, lactic acidosis and narrow pulse pressure is recognised, patients can present, and die, at any point along this spec­trum. Hypotension must be considered in the context of pre-morbid blood pressure and the inuence of chronic illness and concurrent medication use recognised. For instance, a patient with coronary artery disease will be less tolerant of diastolic hypotension, and beta-blocker therapy may mask tachycardia.
17.6 Investigation
Investigation should focus on the anatomic source of infection, the causative organism and complications of the primary infection. Laboratory signs of sepsis per se are often non-specic and arise from the underlying cause of sepsis or con­sequent hypoperfusion and/or organ dysfunction. Common ndings are listed in Box 17.2. Both C-reactive protein and procalcitonin (PCT) have similar sensitivity (0.77 vs. 0.78), specicity (0.79) and area under the receiver operating curve (0.85 vs. 0.86) for identifying sepsis [31]. Serum PCT is elevated in response to bacterial infection and falls during recovery. Furthermore, levels are prognostic. A recent randomised controlled trial and subsequent meta-analysis of over 4000 patients concluded that overall mortality from sepsis was reduced when antimicrobial ini­tiation, de- escalation or cessation was guided by algorithms incorporating PCT measurement [32, 33].
Sterilisation of blood cultures can occur within minutes of administering antibi­otics and it is recommended that, provided substantial delay to antimicrobial admin­istration is not incurred, blood, cerebrospinal uid, sputum, urine or wound cultures
404
https://t.me/medicina_free
Box 17.2
Laboratory ndings consistent with the presence of sepsis
• Leukocytosis or leukopenia
• Normal white cell count with >10% immature forms
• Thrombocytopaenia
• Elevated prothrombin and activated partial thromboplastin time, low brinogen, elevated brin degradation products
• Hyperglycaemia
• Elevated urea and creatinine
• Hyperbilirubinaemia, hypoalbuminaemia, deranged liver enzymes
• Elevated troponin
• Adrenal insufciency (hyponatraemia, hyperkalaemia, normal anion gap acidosis)
• Euthyroid sick syndrome
• Elevated C-reactive protein
• Elevated pro-calcitonin (see text)
• Elevated lactate (tissue hypoperfusion, catecholamine driven aerobic gly­colysis, reduced pyruvate dehydrogenase activity, mitochondrial dysfunction)
B. Reddi
be taken before antibiotics are given when sepsis is suspected. Identifying the organism permits de-escalation of antibiotic therapy reducing antibiotic resistance, side effects, costs and potentially mortality [34]. It is recommended that two or more sets (aerobic and aerobic) of blood cultures be taken. Blood cultures may be drawn together, and yield has not been shown to be improved if timed to tempera­ture spikes [35]. Diagnostic methods such as polymerase chain reaction assays and microarrays are being translated into clinical practice and will hopefully better inform antibiotic prescribing [36].
Other investigations that may be valuable include plain X-ray, CT or MR imag­ing, echocardiographic examination of heart valves, bronchoalveolar lavage or aspi­ration of body uids (e.g. joints).
17.7 Treatment
Sepsis and septic shock are medical emergencies. Resuscitation and treatment should take place immediately and concurrently. The concept of ‘Early Goal Directed Therapy’ (EGDT) was applied to management of septic shock following a seminal study published over a decade ago suggesting that protocolised uid admin­istration, vasopressor therapy, inotrope use and blood transfusion to achieve target mean arterial pressure, central venous pressure and central venous oxygen
17 Sepsis andSeptic Shock
https://t.me/medicina_free
405
saturation was associated with improved survival [37]. Although the benets of ‘protocolised care’ in this single centre study were not replicated in subsequent larger, multi-centre trials this may reect in part an improvement in the ‘usual care’ afforded to patients with sepsis and septic shock [38]. The EGDT concept served to establish sepsis as a clinical entity demanding timely, multifaceted treatment and triggered an effective research program which has culminated in the development of the evidence based Surviving Sepsis Campaign (SSC) Guidelines [39] and a pro­gressive reduction in sepsis mortality. Unless otherwise specied the management approach described in this chapter reects the recommendations of these evidence based guidelines.
17.7.1 Initial Resuscitation
As with any acutely unwell patient the airway should be immediately assessed and secured if necessary. Adequate arterial oxygenation should be achieved using sup­plementary oxygen or assisted ventilation as appropriate. Severe sepsis is the most common cause of ARDS.A lung protective ventilation strategy [40] should be used with consideration of prone positioning, neuromuscular blockade and judicious titration of positive end-expiratory pressure.
Circulatory management is a critical and challenging aspect of sepsis and septic shock management. In patients with septic shock an initial uid bolus of 30mLs/ kg administered within the rst 3h appears safe and is recommended, albeit on limited evidence. More rapid infusion may be warranted in some patients. Crystalloids and colloids appear similarly efcacious [41] although hydroxyethyl starch (HES) is no longer recommended since HES 130/0.42 administration has been associated with poorer outcomes [42]. Balanced crystalloid solutions are a rational option [43, 44]. Where patients have already received substantial volumes of crystalloid there may be a case for continuing uid resuscitation with albumin solution [39]. Following initial uid resuscitation, blood pressure, heart rate, tissue perfusion (including brain, kidney, gut, skin), plasma lactate and mixed venous oxygen saturation (SvO ciency persists and to guide the decision between further uid therapy, vasopressor use or inotropy.
The potential benet of volume expansion, related to an increase in cardiac out­put and oxygen delivery, must be balanced by the risk of aggravating lung and tissue oedema. Fluid therapy should be carefully titrated, prescribing limited volumes with regular re-evaluation are preferable to large volumes with infrequent monitor­ing. Using static measures of uid status such as central venous pressure to guide uid administration in sepsis has been shown to be physiologically awed and clini­cally unreliable [4547]. Instead, dynamic assessment predicts more accurately which patients are likely to respond to a uid bolus with an increase in stroke vol­ume. This can be achieved by passive leg raise, assessment of cardiopulmonary interactions or directly measuring the change in cardiac output following uid
) are re-evaluated to identify whether circulatory insuf-
2
406
https://t.me/medicina_free
B. Reddi
administration [48, 49]. Latterly, recognising the association between positive uid balance and mortality in sepsis [50], a concept of ‘de-resuscitation‘ has gained cur­rency, emphasising the need to limit uid administration in patients who are no longer shocked or uid responsive, and to instigate diuresis once vasopressors are weaned.
In shocked patients with an inadequate or detrimental response to uid therapy, vasopressor support may be warranted. Below a critical mean arterial pressure (MAP) threshold autoregulation is exhausted and vital organ perfusion is limited by MAP. Multiple studies have evaluated the benets of different MAP targets in patients with septic shock treated with vasopressors, ranging from 65 to 85mmHg. Higher pressures have been associated with greater cardiac output, varying effects of tissue perfusion indices and higher rates of arrhythmia [5153]. The only study powered to identify mortality difference found no benet in targeting 65 rather than 85 mmHg, but a reduction in the need for renal replacement therapy amongst patients with chronic hypertension in the higher target pressure group [54]. Although an initial blood pressure target of 65mmHg is reasonable for most patients, higher targets might be considered in patients with a history of chronic hypertension in whom the effective autoregulation range is shifted towards higher pressures. However, blood pressure is not an ends in itself. Once a pressure target is attained, the patient should be re-evaluated for adequacy of tissue perfusion using the clinical indices described above (end-organ function, lactate etc.) and the target reconsid­ered accordingly. Lactate clearance in particular appears to be associated with out­come and resuscitation paradigms centred on promoting resolution of lactic acidosis have shown promise [55]. Once euvolaemia is established, noradrenaline is recom­mended as a rst line vasopressor augmenting both vasomotor tone and cardiac output (through an increase in cardiac preload and contractility) [56]. Vasopressin is noradrenaline-sparing but has an unclear effect on patient-centred outcomes. Vasopressin is an option for cases of refractory vasodilatory shock but its use can be complicated by splanchnic, myocardial and digital ischaemia [57, 58]. Exogenous angiotensin II has also shown promise as a therapeutic option in vasodilatory shock [
59]. Because vasopressor sensitivity is variable throughout the circulation, and
some regions are already relatively ischaemic, administering high doses of exoge­nous vasopressors risks critically impairing vital organ perfusion especially if hypo­volaemia and reduced cardiac output are not addressed.
Although septic shock may be associated with augmented or ‘hyperdynamic’ circulation because of reduced systemic vascular resistance and tachycardia, some patients have either pre-existing or sepsis-related ventricular dysfunction. Echocardiography is an important early adjunct to clinical examination. Findings should be interpreted in the context of the prevailing loading conditions, which greatly inuence stoke volume and ejection fraction and may be profoundly deranged in sepsis. Systolic dysfunction may respond better to inotropic support and strategies to augment cardiac output [60] rather than further uid or vasopressor administration. Dobutamine is a rapidly effective, titratable inotrope which improves indices of tissue perfusion, although it’s use can be complicated by tachyarrhythmia and excessive vasodilation. Dosage should be titrated by monitoring indices of
17 Sepsis andSeptic Shock
https://t.me/medicina_free
tissue perfusion in response to manipulation of cardiac output. As noted above, normal/high SvO2 can be misleading in the presence of impaired oxygen extraction and may not reliably identify impaired cardiac output. Conversely, low SvO2 (<65%) suggests low cardiac output. Levosimendan promotes contractility, relaxation and reduces pulmonary artery pressure whilst circumventing the β-receptor and exhibit­ing a favourable oxygen consumption prole. However, it is costly, difcult to titrate and associated with arguably worse outcomes than standard care [61].
Preliminary human studies indicate that selective β1-adrenergic receptor block­ade (titrated to keep heart rate< 95 bpm) may improve cardiac function, lactate clearance, microvascular blood ow and even survival [62]. Putative mechanisms include augmented diastolic lling and improved myocardial efciency, inhibition of inammatory and pro-apoptotic pathways, and mitigating myocardial catechol­amine toxicity and cytosolic Ca2+ overload.
The use of vasoactive and inotropic agents usually requires continuous invasive arterial pressure monitoring and frequently central venous access. Pulse contour analysis devices or echocardiographic monitoring may be helpful. Because of the need for frequent re-evaluation and advanced physiologic monitoring, patients with severe sepsis and septic shock are generally best managed in an intensive care environment.
407
17.7.2 Antimicrobial Therapy
The benets of early initiation of antimicrobial therapy in patients with septic shock are widely recognised. Each hour delay in delivery of antibiotic is associated with a mortality cost [63] and administration within 1h is recommended as a minimum target. Furthermore, indices of organ dysfunction and length of stay are adversely affected by delayed antibiotic therapy [39]. The data relating timing of antibiotics and outcome in patients with less severe sepsis is less clear. Sepsis is often over­diagnosed [64] and in light of data suggesting that overtreatment may increase mor­tality [65] it is arguable that when a patient is not shocked and has a lower probability of infection, spending time gathering more data to conrm the diagnosis and obtain appropriate microbiology samples is justiable [66].
Initial antibiotic cover should have broad activity against the likely causative pathogens. Inappropriate empiric therapy is associated with up to ve-fold increase in mortality [67]. The choice will be determined by factors such as the patient’s clinical presentation, immune status, recent healthcare facility admission and antibiotic use, and local microbial ecology. Patients who are considered vulnerable to infection with multidrug-resistant gram-negative pathogens such as Pseudomonas, Acinetobacter or Klebsiella should receive a supplementary gram-negative agent in addition to the empiric regime to increase the probability that they receive at least one active agent. Similarly, vancomycin, teicoplanin, or another anti-MRSA agent can be used when risk factors for MRSA exist. Broadening cover in this way, to ensure potential organ­isms are covered by one of the administered agents, is distinct from the concept of